Related Experiment Video

Updated: May 27, 2026

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
08:36

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

Emerging drugs in metastatic breast cancer: an update

Cagatay Arslan1, Kadri Altundag, Omer Dizdar

  • 1Hacettepe University Institute of Oncology, Department of Medical Oncology, Ankara, Turkey.

Expert Opinion on Emerging Drugs
|November 30, 2011
PubMed
Abstract

Insights

Advanced breast cancer treatment is improving, but recurrence remains a challenge. New drug development and overcoming resistance are key research areas for better metastatic breast cancer management.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Screening programs and adjuvant chemotherapy have reduced advanced breast cancer incidence.
  • Recurrence affects over 50% of early-stage breast cancer patients.
  • Developing novel therapies for metastatic breast cancer is a critical research focus.

Purpose of the Study:

  • To review current treatment strategies for metastatic breast cancer.
  • To discuss emerging drugs and overcoming drug resistance.
  • To highlight ongoing research in advanced breast cancer management.

Main Methods:

  • Literature search of PubMed, ASCO, and San Antonio Breast Cancer Symposium abstracts.
  • Analysis of clinical studies and routine clinical usage of agents.
  • Discussion of combination therapies and drug resistance mechanisms.

Main Results:

  • Several drugs have demonstrated survival benefits in advanced breast cancer.
  • Numerous studies are investigating new agents for metastatic disease.
  • Tumor resistance and treatment toxicities are significant challenges.

Conclusions:

  • While progress has been made, a cure for metastatic breast cancer remains elusive.
  • Understanding cancer pathways provides therapeutic targets.
  • Continued development of novel agents and strategies is essential for improving patient outcomes.

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.